Hydatidiform Mole

9 registered clinical trials studyying Hydatidiform Mole — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Multi-center Cohort Study of Hydatidiform Mole in China (CN-HM-01) NCT07202728	Obstetrics & Gynecology Hospital of Fudan University	—
Not Yet Recruiting	A Cohort Study of Hydatidiform Mole NCT05637892	Women's Hospital School Of Medicine Zhejiang University	—
Recruiting	Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule NCT03785574	Women's Hospital School Of Medicine Zhejiang University	N/A
Completed	Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia NCT01535053	GOG Foundation	Phase 3
Unknown	A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform Mole NCT01630954	Nilratan Sircar Medical College	Phase 4
Completed	RCT on the Efficacy of Methotrexate for the Prevention of GTD NCT01984099	University of the Philippines	Phase 3
Completed	A Trial for Patients With Gestational Trophoblastic Disease NCT00190918	Eli Lilly and Company	Phase 2
Recruiting	The French National Reference Centre of GTD NCT02892877	Hospices Civils de Lyon	—
Completed	Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia NCT00003702	Gynecologic Oncology Group	Phase 3